INVEST Precision Medicine Pitch Perfect Health IT and Life Science tracks video highlights
Video from the Health IT and Life Science tracks of our Pitch Perfect contest at INVEST Precision Medicine is now available to view.
Video from the Health IT and Life Science tracks of our Pitch Perfect contest at INVEST Precision Medicine is now available to view.
The INVEST Precision Medicine conference cast a spotlight on the role of children's hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
Intellihealth has developed software that puts patients on a personalized program to lose weight. The startup was named by judges as the winner in the health IT track during the recent MedCity News INVEST Precision Medicine conference.
Experts in precision medicine provide a broad overview of where we are and where we need to go to make the promise and potential of this sector a reality.
A panel discussion on non dilutive funding sources for biopharma and medtech startups from government research and industry grants to industry partnerships and venture debt.
This panel highlights how different organizations in the biopharma supply chain are addressing the inherent challenges of producing and delivering cell and gene therapies and biologics.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
This panel explores some of the diverse approaches companies are taking to improve efficiency and avert pitfalls in therapeutic development.
Targeted therapies for certain types of cancer and rare disease offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?
Ten companies presented an overview of their businesses in the health IT and life science tracks of Pitch Perfect. Two winners emerged. Here's a look at who won and why.
Panelists at MedCity INVEST Precision Medicine said startups can gain valuable expertise and experience through the process of seeking out non-dilutive funding.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Cell and gene therapy companies currently each have their own "cookie recipe" for manufacturing. But to scale, more standardization is needed, experts said.
The clinical trial arena is changing rapidly, driven largely by the acceleration of telehealth usage and the potential provided by new data solutions. Panelists at MedCity INVEST Precision Medicine agreed that clinical trials will never be conducted in the same way again.
Register for INVEST Precision Medicine to check out the life science track of the Pitch Perfect startup contest and hear compelling panel discussions on software supporting biopharma R&D, and the supply chain challenges of scaling production and delivering personalized therapies.
Minority groups get left out of clinical trials and studies for many reasons, including lack of access, awareness and trust in the healthcare system. But, according to panelists at MedCity INVEST Precision Medicine, researchers along with patient advocates can help tackle these hurdles by working together and being intentional in their approach.
Children's hospitals are launching big efforts to identify more rare diseases through genome sequencing. Even as new treatments become available, many families struggle to reach a diagnosis.